Gene therapy to improve osteogenesis in bone lesions with severe soft tissue damage

Langenbeck's Archives of Surgery

Volumn 388, Issue 5, 2003, Pages 356-365

  Rose, Tim ^a,b,c   Peng, Hairong ^b   Usas, Arvydas ^b   Kuroda, Ryosuke ^b,c   Lill, Helmut ^a   Fu, Freddie H ^c   Huard, Johnny ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bone healing; Bone morphogenetic proteins; Ex vivo gene therapy; Soft tissue damage

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE DEVELOPMENT; BONE LESION; CALLUS; CARTILAGE CELL; CONFERENCE PAPER; FEMUR OSTEOTOMY; FRACTURE FIXATION; GENE; GENE THERAPY; LACZ GENE; NONHUMAN; OSSIFICATION; OSTEOCHONDRAL OSSIFICATION; PRIORITY JOURNAL; RAT; SOFT TISSUE INJURY;

ANIMALS; BONE REGENERATION; BONY CALLUS; CELLS, CULTURED; CHONDROCYTES; FEMALE; FEMORAL FRACTURES; FRACTURE HEALING; GENE THERAPY; GENETIC VECTORS; LAC OPERON; MUSCLE, SKELETAL; OSTEOGENESIS; PERIOSTEUM; RATS; RATS, INBRED F344; RETROVIRIDAE; SOFT TISSUE INJURIES; TRANSDUCTION, GENETIC; WOUND HEALING;

EID: 0242485423     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-003-0403-5     Document Type: Conference Paper

References (44)

1. Bax BE, Wozney JM, Ashhurst DE (1999) Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif Tissue Int 65:83-89
2. Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS (1998) Laparoscopic anterior spinal arthrodesi with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 11:95-101
3. Boden SD, Martin GJ Jr, Morone M, Ugbo JL, Titus L, Hutton WC (1999) The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 24:320-327
4. Boden SD, Martin GJ Jr, Morone MA, Ugbo JL, Moskovitz PA (1999) Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 24:1179-1185
5. Bosch P, Musgrave DS, Lee JY, Cummins J, Shuler T, Ghivizzani TC, Evans T, Robbins TD, Huard J (2000) Osteoprogenitor cells within skeletal muscle. J Orthop Res 18:933-944
6. Bostrom M, Lane JM, Tomin E, Browne M, Berberian W, Turek T, Smith J, Wozney J, Schildhauer T (1996) Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop (327):272-282
7. Bostrom MP (1998) Expression of bone morphogenetic proteins in fracture healing. Clin Orthop 355 [Suppl]:S116-123
8. Brownlow HC, Simpson AH (2000) Metabolic activity of a new atrophic nonunion model in rabbits. J Orthop Res 18:438-442
9. Brownlow HC, Reed A, Simpson AH (2001) Growth factor expression during the development of atrophic non-union. Injury 32:519-524
10. Brownlow HC, Reed A, Simpson AH (2002) The vascularity of atrophic non-unions. Injury 33:145-150
11. Chen X, Kidder LS, Lew WD (2002) Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur. J Orthop Res 20:142-150
12. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC (1994) Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 301:302-312
13. Einhorn TA (1998) The cell and molecular biology of fracture healing. Clin Orthop 355 [Suppl]:S7-21
14. Ham A (1930) A histological study of the early phases of bone repair. J Bone Joint Surg Am 12:827-844
15. Hanada K, Solchaga LA, Caplan AI, Hering TM, Goldberg VM, Yoo JU, Johnstone B (2001) BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem 81:284-294
16. Hecht BP, Fischgrund JS, Herkowitz HN, Penman L, Toth JM, Shirkhoda A (1999) The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine 24:629-636
17. Hietaniemi K, Peltonen J, Paavolainen P (1995) An experimental model for non-union in rats. Injury 26:681-686
18. Ito Y, Fitzsimmons JS, Sanyal A, Mello MA, Mukherjee N, O'Driscoll SW (2001) Localization of chondrocyte precursors in periosteum. Osteoarthritis Cartilage 9:215-223
19. Jortikka L, Laitinen M, Wiklund J, Lindholm TS, Marttinen A (1998) Use of myoblasts in assaying the osteoinductivity of bone morphogenetic proteins. Life Sci 62:2359-2368
20. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766
21. Kettunen J, Makela EA, Turunen V, Suomalainen O, Partanen K (2002) Percutaneous bone grafting in the treatment of the delayed union and non-union of tibial fractures. Injury 33:239-245
22. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB (2000) Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 11:1201-1210
23. Lee JY, Qu-Petersen Z, Cao B, Kimura S, Jankowski R, Cummins J, Usas A, Gates C, Robbins P, Wernig A, Huard J (2000) Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150:1085-1100
24. Lee JY, Musgrave D, Pelinkovic D, Fukushima K, Cummins J, Usas A, Robbins P, Fu FH, Huard J (2001) Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 83:1032-1039
25. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GA, Berk AJ, Witte ON (1999) The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81:905-917
26. Molster AO, Gjerdet NR (1984) Effects of instability on fracture healing in the rat. Acta Orthop Scand 55:342-346
27. Musgrave DS, Bosch P, Lee JY, Pelinkovic D, Ghivizzani SC, Whalen J, Niyibizi C, Huard J (2000) Ex vivo gene therapy to produce bone using different cell types. Clin Orthop 378:290-305
28. Musgrave DS, Pruchnic R, Bosch P, Ziran BH, Whalen J, Huard J (2002) Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br 84:120-127
29. Nakahara H, Bruder SP, Haynesworth SE, Holecek JJ, Baber MA, Goldberg VM, Caplan AI (1990) Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 11:181-188
30. Nathanson MA, Hay ED (1980) Analysis of cartilage differentiation from skeletal muscle grown on bone matrix. I. Ultrastructural aspects. Dev Biol 78:301-331
31. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath TK, ten Dijke P, Sakou T (1998) Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 22:605-612
32. Ozaki A, Tsunoda M, Kinoshita S, Saura R (2000) Role of fracture hematoma and periosteum during fracture healing in rats: interaction of fracture hematoma and the periosteum in the initial step of the healing process. J Orthop Sci 5:64-70
33. Qu Z, Huard J (2000) Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther 7:428-437
34. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142:1257-1267
35. Reddi AH (1997) Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 8:11-20
36. Reddi AH, Cunningham NS (1993) Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8:S499-502
37. Ripamonti U, Van Den Heever B, Sampath TK, Tucker MM, Rueger DC, Reddi AH (1996) Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 13:273-89, colour plates III-VIII
38. Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegen EN, Liu D, Seeger LL, Dawson EG (1995) Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 20:2669-2682
39. Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegen EN, Liu D, Delamarter RB, Dawson EG (1996) Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21:2115-2122
40. Sudkamp NP, Haas NP, Sinnig M, Sottmann G, Tscherne H (1993) Incidence of pseudarthroses in open fractures: analysis of 948 open fractures. Aktuelle Traumatol 23:59-67
41. Takagi K, Urist MR (1982) The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin Orthop 171:224-231
42. Urist MR (1965) Bone: formation by autoinduction. Science 150:893-899
43. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687
44. Yoon ST, Boden SD (2002) Osteoinductive molecules in orthopaedics: basic science and preclinical studies. Clin Orthop 395:33-43